# US 2008/0188007 A1 · Fluorescent single chain antibody and its use in detection of analytes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188007 A1
- Document ID: US20080188007A1
- Status: Published application
- Kind: A1
- Application number: 11/702,812
- Filed: 2007-02-06
- Published: 2008-08-07
- Earliest claimed: 2007-02-06
- Assignees: Meridian Life Science, Inc.
- Inventors: K. John Morrow; Xiaokang Deng; Robert F. Devlin; Preston H. Dorsett
- Web page: https://patentgrep.com/patent/US20080188007A1

## CPC

- C07K 16/1282: Clostridium (G)
- G01N 33/536: with immune complex formed in liquid phase
- G01N 33/582: {with fluorescent label}
- C07K 2317/622: Single chain antibody (scFv)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A fluorescent single chain antibody construct is provided comprising a single chain antibody reactive with a target analyte and conjugated with a fluorophore. Also provided is a method for rapid and accurate detection of analytes using the fluorescent single chain antibody construct thereof. Further provided is a diagnostic kit for detecting pathogens using a fluorescent single chain antibody construct comprising a single chain antibody reactive with pathogen-related antigens and conjugated with a fluorophore.

## Claims

### Claim 1

A fluorescent single chain antibody construct comprising:
(a) a single chain antibody consisting of an antigen binding region of a light chain, an antigen binding region of a heavy chain and a flexible linker connecting said antigen binding region of said light chain and said antigen binding region of said heavy chain; and
(b) a fluorophore conjugated to said single chain antibody.

### Claim 2 (depends on 1)

The fluorescent single chain antibody construct of claim 1, wherein said single chain antibody is monomeric with a molecular weight of 25-30 kD, or dimeric with a molecular weight of 50-60 kD.

### Claim 3 (depends on 1)

The fluorescent single chain antibody construct of claim 1, wherein said fluorophore is fluorescein isothiocyanate, phthalocyanine dye La Jolla Blue or any other suitable fluorchrome.

### Claim 4 (depends on 1)

A method for detecting the presence of an analyte in a sample, comprising the steps of:
(a) preparing a buffered solution of said sample;
(b) adding to said buffered solution a fluorescent single chain antibody construct according to claim 1, wherein said construct is reactive with said analyte;
(c) incubating for a period of time sufficient to permit reaction to take place between said sample and said fluorescent single chain antibody construct to produce a reaction product; and
(d) measuring the degree of fluorescence polarization in said reaction product; wherein an increase of said degree of fluorescence polarization in said reaction product as compared to degree of fluorescence polarization of said single chain antibody construct is indicative of the presence of said analyte in said sample.

### Claim 5 (depends on 4)

The method of claim 4, wherein said analyte is a protein or other high molecular weight entity.

### Claim 6 (depends on 5)

The method of claim 5, wherein said analyte is an antigen.

### Claim 7 (depends on 6)

The method of claim 6, wherein said analyte is a pathogen-related antigen.

### Claim 8 (depends on 4)

The method of claim 4, wherein said single chain antibody is monomeric with a molecular weight of 25-30 kD, or dimeric with a molecular weight of 50-60 kD.

### Claim 9 (depends on 4)

The method of claim 4, wherein said fluorophore is fluorescein isothiocynate, phthalocyanine dye La Jolla Blue or any other suitable fluorchrome.

### Claim 10 (depends on 4)

The method of claim 4, where said buffer solution is a phosphate buffered saline solution.

### Claim 11 (depends on 1)

A method for diagnosing a pathologic condition in a subject, comprising the steps of:
(a) preparing a buffered solution of a specimen from said subject;
(b) adding to said buffered solution a fluorescent single chain antibody construct according to claim 1, wherein said construct is reactive with an antigen, and said antigen is related to a pathogen specific for said pathologic condition;
(c) incubating for a period of time sufficient to permit reaction to take place between said specimen and fluorescent single chain antibody construct to produce a reaction product; and
(d) measuring the degree of fluorescence polarization in said reaction product; wherein an increase of said degree of fluorescence polarization in said reaction product as compared to degree of fluorescence polarization of said single chain antibody construct is indicative of the presence of said pathogen in said specimen, which is thereby indicative of said pathologic condition in said subject.

### Claim 12 (depends on 11)

The method of claim 11, wherein said single chain antibody is monomeric with a molecular weight of 25-30 kD, or dimeric with a molecular weight of 50-60 kD.

### Claim 13 (depends on 11)

The method of claim 11, wherein the fluorophore is fluorescein isothiocynate, phthalocyanine dye La Jolla Blue or any other suitable fluorchrome.

### Claim 14 (depends on 11)

The method of claim 11, where the buffer solution is a phosphate buffered saline solution.

### Claim 15 (depends on 1)

A diagnostic kit for detecting the presence of an infectious pathogen, comprising:
(a) a diagnostically effective amount of a fluorescent single chain antibody construct according to claim 1; and
(b) a suitable container,
wherein said fluorescent single chain antibody construct is reactive with an antigen related to said pathogen.

### Claim 16 (depends on 15)

The diagnostic kit of claim 15, wherein said antigen is a protein or other high molecular weight entity.

### Claim 17 (depends on 15)

The diagnostic kit of claim 15, wherein said single chain antibody is monomeric with a molecular weight of 25-30 kD, or dimeric with a molecular weight of 50-60 kD.

### Claim 18 (depends on 15)

The diagnostic kit of claim 15, wherein the fluorophore is fluorescein isothiocynate, phthalocyanine dye La Jolla Blue or any other suitable fluorchrome.

### Claim 19 (depends on 2)

The fluorescent single chain antibody construct of claim 2, wherein said single chain antibody comprises a sequence as set forth in SEQ ID NO:2 or SEQ ID NO:4.

### Claim 20 (depends on 19)

The fluorescent single chain antibody construct of claim 19, wherein said single chain antibody is encoded by a sequence as set forth in SEQ ID NO:1 or SEQ ID NO:3.

### Claim 21 (depends on 8)

The method of claim 8, wherein said single chain antibody comprises a sequence as set forth in SEQ ID NO:2 or SEQ ID NO:4.

### Claim 22 (depends on 21)

The method of claim 21, wherein said single chain antibody is encoded by a sequence as set forth in SEQ ID NO:1 or SEQ ID NO:3.

### Claim 23 (depends on 12)

The method of claim 12, wherein said single chain antibody comprises a sequence as set forth in SEQ ID NO:2 or SEQ ID NO:4.

### Claim 24 (depends on 23)

The method of claim 23, wherein said single chain antibody is encoded by a sequence as set forth in SEQ ID NO:1 or SEQ ID NO:3.

### Claim 25 (depends on 17)

The diagnostic kit of claim 17, wherein said single chain antibody comprises a sequence as set forth in SEQ ID NO:2 or SEQ ID NO:4.

### Claim 26 (depends on 25)

The diagnostic kit of claim 25, wherein said single chain antibody is encoded by a sequence as set forth in SEQ ID NO:1 or SEQ ID NO:3.

### Claim 27

A single chain antibody comprising a sequence as set forth in SEQ ID NO:2 or SEQ ID NO:4.

### Claim 28 (depends on 27)

The single chain antibody of claim 27, wherein said single chain antibody is encoded by a sequence as set forth in SEQ ID NO:1 or SEQ ID NO:3.
